Aug 21, 2019 · Dr. Clifford Hudis. Clifford A. Hudis, MD, FACP, FASCO, CEO of ASCO, recently interviewed Lisa Lacasse, president of the American Cancer Society Cancer Action Network, as part of the ASCO in Action Podcast series.

Nov 1, 2023 · Author Bios. Dr. Lori M. Minasian is deputy director for the Division of Cancer Prevention at the National Cancer Institute.. Dr. Paul F. Pinsky is chief of the Early Detection Research Branch for the Division of Cancer Prevention at the National Cancer Institute.. Dr. Christos Patriotis is a program officer in the Cancer Biomarkers Research Group for the Division of Cancer Prevention at the ...

Mar 18, 2024 · ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual. ASCO Guidelines follow ...

Feb 26, 2019 · 45Background: Does tumor location affect prostate cancer prognosis? To clarify this question we conducted a retrospective study to characterize the incidence and prognostic significance of tumor location of prostate cancer. Methods: From 2000 to 2017, ...

Aug 19, 2022 · References. Parry EM, Gable DL, Stanley SE, et al. Germline mutations in DNA repair genes in lung adenocarcinoma. J Thorac Oncol. 2017;12:1673-1678.; Slavin TP, Banks KC, Chudova D, et al. Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing [published online ahead of print, 2018 Oct 19].

Jun 5, 2023 · References. Modi S, Saura C, Yamashita T, et al. Trastuzumab deruxtecan in previously treated HER2-positive breast cancer. N Engl J Med. 2020;382(7):610-621.; Modi S, Jacot W, Yamashita T, et al. Trastuzumab deruxtecan in previously treated HER2-low …

The phase 3 STARTER-NET trial found that everolimus plus lanreotide more than doubles progression-free survival among patients with aggressive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) versus everolimus therapy alone, and …

Feb 2, 2023 · Author Bios. Dr. Luca Valle is an assistant professor in the department of radiation oncology at University of California, Los Angeles.. Dr. Wolfgang Lilleby is a senior consultant and group leader of uro-oncology research.. Dr. Matthew Rettig is a professor in the division of medical oncology as well as the medical director of the Prostate Cancer Research Program of the Institute of Urologic ...

Feb 23, 2022 · Non–small cell lung cancer (NSCLC) constitutes 80% to 85% of all lung cancers. Surgical resection offers the best opportunity for survival in the early stages, yet a high risk of developing recurrent disease remains.

May 15, 2024 · Evidence-based recommendations address the integration of palliative care in oncology. Oncology clinicians should refer patients with advanced solid tumors and hematologic malignancies to specialized interdisciplinary palliative care teams that provide outpatient and inpatient care beginning early in the course of the disease, …